Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
5 Good Opportunities on Relative Price Strength Strategy
09:46am, Tuesday, 26'th Dec 2023
AMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength.
3 Stocks at the Forefront of Medical Innovation
08:23pm, Monday, 25'th Dec 2023
Innovation in the medical world is undoubtedly a fundamental pillar in the development of humanity. There are great companies within the biotech sector doing wonderful work, research, and developments
3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock
02:16pm, Monday, 25'th Dec 2023
Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
What's in Store for Nasdaq in 2024? 5 Top Picks
09:01am, Tuesday, 12'th Dec 2023
After a strong 2023, we expect the Nasdaq to log gains in 2024. Top-ranked Nasdaq stocks GigaCloud Technology Inc (GCT), Carrols Restaurant Group (TAST), Limbach (LMB), Amphastar Pharmaceuticals (AMPH
Snap These 4 Top-Performing Liquid Stocks for Strong Returns
07:31am, Monday, 11'th Dec 2023
Here are four top-ranked liquid stocks, Puma Biotechnology (PBYI), Amphastar Pharmaceuticals (AMPH), DropBox (DBX) and GigaCloud Technology Inc. (GCT), which investors can add to their portfolio for s
3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)
02:17pm, Friday, 08'th Dec 2023
Amphastar (AMPH) could produce exceptional returns because of its solid growth attributes.
Are You Looking for a Top Momentum Pick? Why Amphastar Pharmaceuticals (AMPH) is a Great Choice
01:32pm, Tuesday, 05'th Dec 2023
Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
3 Best Momentum Stocks to Buy Using the Driehaus Strategy
07:31am, Tuesday, 05'th Dec 2023
Stocks like Abercrombie & Fitch (ANF), Amphastar Pharmaceuticals (AMPH) and NetEase (NTES) have been selected as the momentum picks for the day using the Driehaus strategy.
This Biotech Stock Nears A Buy Point After 200% Profit Growth
06:13pm, Thursday, 30'th Nov 2023
This biotech stock is in a base after the company produced triple-digit earnings growth. AMPH stock is poised for a move.
4 Top-Performing Liquid Stock Picks for Robust Returns
09:46am, Thursday, 30'th Nov 2023
Here are four top-ranked liquid stocks, Puma Biotechnology (PBYI), Amphastar Pharmaceuticals (AMPH), DropBox (DBX), and Vimeo (VMEO), which investors can add to their portfolio for solid gains.
3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)
02:17pm, Wednesday, 22'nd Nov 2023
Amphastar (AMPH) possesses solid growth attributes, which could help it handily outperform the market.
Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
04:20pm, Monday, 20'th Nov 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 20, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, S.V.P. of Corporate Communications, will p
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
04:05pm, Thursday, 09'th Nov 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 9, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi EVP of Corp. Administration, will parti
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Call Transcript
10:39pm, Wednesday, 08'th Nov 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Dan Dischner - SVP of Corporate Communications Bill Peters - CFO Confer
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023
04:10pm, Wednesday, 01'st Nov 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2023 ended September 30, 2
